Brian Savage insider trades

Open-market stock purchases and sales by Brian Savage, Interim Chief Legal Officer at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Mar 3, 2026.

Recent trades

DateStockTradeValue
Sep 18, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)$156K
Sep 18, 2026TEVA Teva Pharmaceutical Industries LtdSold$174K
Sep 18, 2026TEVA Teva Pharmaceutical Industries LtdSold$98.8K
Sep 18, 2026TEVA Teva Pharmaceutical Industries LtdSold$12.2K
Sep 18, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)$156K
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdSold$35.7K
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdSold$48.3K
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdSold$38.5K
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdSold$41.2K
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—

Companies traded

  • TEVA Teva Pharmaceutical Industries Ltd: 7 sales, last Sep 18, 2026

Get free alerts when Brian Savage files a new trade →